26-Sep-16 Small specialised hospitals in India are planning to collaborate to expand services across the country by pooling medical expertise for maximum efficiency. “We have strong investment backing... We have planned expansion to increase to 1,000-bed facilities, from the current 108-bed hospital in Bangalore,” said Dr Anil Mehta, MD of Bangalore-based Nandana Healthcare. [image: Medical Dialogues]
Read More
23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]
Read More
21-Sep-16 SK has signed an MOU with Korea University on the development of the 'Aibril' Infectious Disease AI Diagnosis Service, based on Watson. This will be a world first, as up to now AI-based medical services have been mainly limited to diagnosing cancers. No-one has yet provided AI medical services for infectious diseases such as Middle East Respiratory Syndrome and Cholera. [image: Business Korea]
Read More
19-Sep-16 With China's demographic shifting towards an ever-higher ratio of citizens aged 60-plus, elder-friendly wearables are seen as a key means of monitoring the health and whereabouts of this affluent, yet vulnerable, sector of contemporary society. In the elderly sector, wearables tend to be either tracking devices or fall alarms. [image: HKTDC Research]
Read More
18-Sep-16 A growing number of Singaporean women are heading to Malaysia, Thailand and Australia to preserve their fertility, in the hope of having children when they finally marry Mr Right. These women - professionals in their mid-30s to early 40s - are getting their eggs frozen abroad as the procedure is not allowed in Singapore, except on medical grounds. [image: ST Illustration / Adam Lee]
Read MoreGlobal Growth Markets is an intelligence, advisory and local execution firm helping clients identify opportunities, secure capital and grow their business.
We believe the only way to understand a market properly is on the ground. Our in-country experts, combined with AI-optimized analysis, give you a competitive advantage in over 40 markets across the Americas, EMEA and Asia-Pacific.
Our clients benefit from strategic insights, reduced risk and operational support, giving them the confidence to succeed in their global growth markets.
Value for money – real results at affordable rates
Work led by senior directors with >20 years track record
In-country presence across the Americas, EMEA and Asia-Pacific
Investor and private capital network built over decades
Proven frameworks for reliable insights and pragmatic advice
Boots on the ground supporting local execution
Find out more about our intelligence, advisory and execution services
Get in touch to discuss your growth markets needs:
Email: info@ggmkts.com
Follow us: